VACCITECH
Vaccitech is a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer. The company’s proprietary platform comprises proprietary modified simian adenoviral vectors, known as ChAdOx1 and ChAdOx2, as well as the well-validated Modified Vaccinia Ankara, or MVA, boost vector, both with demonstrable safety profiles and without the ability to replicate in humans. The ... combination of a ChAdOx prime treatment with subsequent MVA boost has consistently generated significantly higher magnitudes of CD8+ T cells compared with other technologies and approaches. The company has a broad pipeline of both clinical and preclinical stage therapeutic programs in solid tumors and viral infections and prophylactic viral vaccine programs. Vaccitech co-invented a COVID-19 vaccine with the University of Oxford, now approved for use in many territories and exclusively licensed worldwide to AstraZeneca through Oxford University Innovation, or OUI. Vaccitech is entitled to receive a share of the milestones and royalty income received by OUI from AstraZeneca.
VACCITECH
Social Links:
Industry:
Biotechnology Medical Pharmaceutical Therapeutics
Founded:
2016-01-01
Address:
Oxford, Oxfordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.vaccitech.co.uk
Total Employee:
11+
Status:
Active
Contact:
+44 01865 818808
Email Addresses:
[email protected]
Total Funding:
215.56 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-12-13 | Avidea Technologies | Avidea Technologies acquired by Vaccitech | 40 M USD |
Investors List
Tencent
Tencent investment in Series B - Vaccitech
M&G Investments
M&G Investments investment in Series B - Vaccitech
Gilead Sciences
Gilead Sciences investment in Series B - Vaccitech
Monaco Constitutional Reserve Fund
Monaco Constitutional Reserve Fund investment in Series B - Vaccitech
Future Planet Capital
Future Planet Capital investment in Series B - Vaccitech
Oxford Science Enterprises
Oxford Science Enterprises investment in Series B - Vaccitech
Future Planet Capital
Future Planet Capital investment in Convertible Note - Vaccitech
GeneMatrix
GeneMatrix investment in Series A - Vaccitech
Korea Investment Partners
Korea Investment Partners investment in Series A - Vaccitech
Xfund
Xfund investment in Series A - Vaccitech
Key Employee Changes
| Date | New article |
|---|---|
| 2020-10-20 | Vaccitech expands management team with hires including CMO and CFO |
Official Site Inspections
http://www.vaccitech.co.uk Semrush global rank: 2.65 M Semrush visits lastest month: 6.41 K
- Host name: 151.101.66.159
- IP address: 151.101.66.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
